These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17145931)

  • 1. Anti-HIV activity of steric block oligonucleotides.
    Ivanova G; Arzumanov AA; Turner JJ; Reigadas S; Toulmé JJ; Brown DE; Lever AM; Gait MJ
    Ann N Y Acad Sci; 2006 Oct; 1082():103-15. PubMed ID: 17145931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
    Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
    Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs.
    Brown D; Arzumanov AA; Turner JJ; Stetsenko DA; Lever AM; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):393-6. PubMed ID: 16247957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
    Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery.
    Turner JJ; Fabani M; Arzumanov AA; Ivanova G; Gait MJ
    Biochim Biophys Acta; 2006 Mar; 1758(3):290-300. PubMed ID: 16337923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of polyamide nucleic-acid-cell penetrating peptide conjugates targeted against HIV-1 transactivation response element.
    Ganguly S; Chaubey B; Tripathi S; Upadhyay A; Neti PV; Howell RW; Pandey VN
    Oligonucleotides; 2008 Sep; 18(3):277-86. PubMed ID: 18729823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties.
    Chaubey B; Tripathi S; Ganguly S; Harris D; Casale RA; Pandey VN
    Virology; 2005 Jan; 331(2):418-28. PubMed ID: 15629784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
    Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
    Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.
    Arzumanov A; Walsh AP; Liu X; Rajwanshi VK; Wengel J; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):471-80. PubMed ID: 11563062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N; Basu A; Pandey VN
    Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological response to peptide nucleic acid and its peptide conjugate targeted to transactivation response (TAR) region of HIV-1 RNA genome.
    Upadhyay A; Ponzio NM; Pandey VN
    Oligonucleotides; 2008 Dec; 18(4):329-35. PubMed ID: 19006449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.
    Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN
    J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
    Turner JJ; Jones S; Fabani MM; Ivanova G; Arzumanov AA; Gait MJ
    Blood Cells Mol Dis; 2007; 38(1):1-7. PubMed ID: 17113327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
    Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
    Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell penetrating peptide conjugates of steric block oligonucleotides.
    Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):517-29. PubMed ID: 18037527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues.
    Holmes SC; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2003 Jun; 31(11):2759-68. PubMed ID: 12771202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.